BELLEVUE GROUP AG Esperion Therapeutics, Inc. Transaction History

BELLEVUE GROUP AG portfolio value:

$28.30M
portfolio value

BELLEVUE GROUP AG quarter portfolio value change:

+5.35%
quarter

Esperion Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -0.24% -10K shares 1.37M $6.7 4.22M
Q2 2022 share Decrease -1.49% -63.9K shares 6.98M $6.36 4.23M
Q1 2022 share Decrease -4.87% -220K shares -2.64M $4.64 4.29M
Q4 2021 share 0.00% 0 shares -31.85M $4.96 4.51M
Q3 2021 share 0.00% 0 shares -41.12M $12.05 4.51M
Q2 2021 share Increase +13.29% 530K shares -16.31M $21.15 4.51M
Q1 2021 share Decrease -22.37% -1.14M shares -21.70M $28.05 3.98M
Q4 2020 share Decrease -5.99% -327.26K shares -69.56M $26 5.13M
Q3 2020 share Increase +3.07% 162.58K shares -68.94M $37.17 5.46M
Q2 2020 share Increase +5.27% 265.24K shares 113.26M $51.31 5.30M
Q1 2020 share Increase +11.33% 512.88K shares -110.98M $31.53 5.03M
Q4 2019 share Increase +6.69% 283.54K shares 114.33M $59.63 4.52M
Q3 2019 share Increase +4.54% 184.05K shares -33.25M $36.66 4.24M
Q2 2019 share Increase +718.77% 3.56M shares 168.85M $46.52 4.05M
Q1 2019 share Increase +9.64% 43.57K shares -895K $40.15 495.54K
Q4 2018 share Increase +15.34% 60.12K shares 3.40M $46 451.97K
Q3 2018 share Increase +24.98% 78.33K shares 5.09M $44.37 391.85K
Q2 2018 share Increase +81.52% 140.8K shares -206K $39.19 313.52K
Q1 2018 share Increase +2114.36% 164.92K shares 11.97M $72.33 172.72K
Q4 2017 share Decrease -2.50% -200 shares 113K $65.84 7.8K
Q3 2017 share 0.00% 0 shares 31K $50.12 8K
Q2 2017 share Decrease -75.00% -24K shares -760K $46.28 8K
Q1 2017 share Decrease -20.00% -8K shares 629K $35.31 32K
Q4 2016 share 0.00% 0 shares -53K $12.52 40K
Q3 2016 share 0.00% 0 shares 159K $13.85 40K
Q2 2016 share 0.00% 0 shares -281K $9.88 40K
Q1 2016 share Increase 0.00% 40K shares 676K $16.91 40K